Sundrug CoSDGCF 79 Receivables Turnover is 6.29 as of Mar. 2026. GuruFocus rates SDGCF with a GF Score™ of 79/100 and a GF Value™ of $34.88. The stock has 1 warning sign investors should review. Among 655 Healthcare Providers & Services companies, Sundrug Co ranks better than 89.01% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Sundrug Co's Revenue for the
three
months ended in Mar. 2026 was $1,303 Mil. Sundrug Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was $207 Mil.
Hence, Sundrug Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 6.29.
Sundrug Co (OTCPK:SDGCF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Sundrug Co Receivables Turnover Related Terms
Sundrug Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Sundrug Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co Receivables Turnover Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sundrug Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Sundrug Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co (SDGCF) has a Receivables Turnover of 6.29 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sundrug Co and its competitors. According to the industry distribution chart, Sundrug Co ranks #72 out of 655 companies in the Healthcare Providers & Services industry, placing it in the top 11%.
Is Sundrug Co's Receivables Turnover too high?
Sundrug Co's current Receivables Turnover is 6.29. The Healthcare Providers & Services industry median Receivables Turnover is 7.70. Sundrug Co's value of 6.29 is 18.3% below this industry median. Based on the distribution chart, Sundrug Co ranks #72 out of 655 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sundrug Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Receivables Turnover compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #72 out of 655 companies for Receivables Turnover. This places Sundrug Co in the top 11% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.70. Sundrug Co's value of 6.29 is 18.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.70, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current Receivables Turnover of 6.29 is 18.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current Receivables Turnover is 6.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Sundrug Co (SDGCF) has a current Receivables Turnover of 6.29. The stock's GF Value™ is $34.88, compared to a current price of $28.18 — trading 19.2% below its estimated fair value. The current Receivables Turnover is 6.29 and 18.3% below the Healthcare Providers & Services industry median of 7.70. Sundrug Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Sundrug Co (SDGCF), the current Receivables Turnover is 6.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (SDGCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of $28.18 is trading 19.2% below its estimated GF Value™ of $34.88.
Key valuation signals for SDGCF:
Receivables Turnover: 6.29
GF Value™: $34.88 vs. price of $28.18 (19.2% below fair value)
Industry Position: 18.3% below the Healthcare Providers & Services median (#72 of 655)
No single metric tells the full story. See the SDGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
79GF Score
Get the complete analysis for SDGCF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDGCF has been successfully added to your 
